Published in Am J Cardiol on February 13, 2010
First report of 90-day support of 2 calves with a continuous-flow total artificial heart. J Thorac Cardiovasc Surg (2015) 1.73
The total artificial heart. J Thorac Dis (2015) 1.39
Right heart failure post left ventricular assist device implantation. J Thorac Dis (2014) 1.37
Assessment and treatment of right ventricular failure. Nat Rev Cardiol (2013) 1.22
Temporary percutaneous right ventricular support using a centrifugal pump in patients with postoperative acute refractory right ventricular failure after left ventricular assist device implantation. Eur J Cardiothorac Surg (2012) 1.18
Predicting right ventricular failure in the modern, continuous flow left ventricular assist device era. Ann Thorac Surg (2013) 1.09
Outcomes and predictors of early mortality after continuous-flow left ventricular assist device implantation as a bridge to transplantation. ASAIO J (2014) 0.91
Dealing with surgical left ventricular assist device complications. J Thorac Dis (2015) 0.90
A new Bayesian network-based risk stratification model for prediction of short-term and long-term LVAD mortality. ASAIO J (2015) 0.89
Miniaturization of mechanical circulatory support systems. Artif Organs (2012) 0.87
Use of Heart Failure Medical Therapies Among Patients With Left Ventricular Assist Devices: Insights From INTERMACS. J Card Fail (2016) 0.81
Mechanical Circulatory Support and the Role of LVADs in Heart Failure Therapy. Clin Med Insights Cardiol (2015) 0.81
Assessment of right ventricular function in left ventricular assist device candidates. Circ Cardiovasc Imaging (2014) 0.81
Continuous flow left ventricular assist device implant significantly improves pulmonary hypertension, right ventricular contractility, and tricuspid valve competence. J Card Surg (2013) 0.80
Predictors of right ventricular failure after left ventricular assist device implantation. Croat Med J (2014) 0.80
Ventricular assist devices: pharmacological aspects of a mechanical therapy. Pharmacol Ther (2012) 0.80
Right ventricular dysfunction following continuous flow left ventricular assist device placement in 51 patients: predicators and outcomes. J Cardiothorac Surg (2012) 0.79
Predictors and management of right heart failure after left ventricular assist device implantation. Methodist Debakey Cardiovasc J (2015) 0.79
Implantation of the syncardia total artificial heart. J Vis Exp (2014) 0.78
Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock. Crit Care (2015) 0.78
A modified Glenn shunt reduces venous congestion during acute right ventricular failure due to pulmonary banding: a randomized experimental study. Interact Cardiovasc Thorac Surg (2014) 0.77
The Right Ventricular Function After Left Ventricular Assist Device (RVF-LVAD) study: rationale and preliminary results. Eur Heart J Cardiovasc Imaging (2015) 0.77
Right side of heart failure. Heart Fail Rev (2012) 0.77
Lung perfusion and ventilation during implantation of left ventricular assist device as a strategy to avoid postoperative pulmonary complications and right ventricular failure. Interact Cardiovasc Thorac Surg (2013) 0.76
Medical management of patients with continuous-flow left ventricular assist devices. Curr Treat Options Cardiovasc Med (2014) 0.76
Right ventricular function and left ventricular assist device placement: clinical considerations and outcomes. Ochsner J (2010) 0.75
Orthotopic Heart Transplantation and Mechanical Circulatory Support in Cancer Survivors: Challenges and Outcomes. J Oncol (2015) 0.75
Left ventricular assist device implantation strategies and outcomes. J Thorac Dis (2015) 0.75
Right ventricular unloading and respiratory support with a wearable artificial pump-lung in an ovine model. J Heart Lung Transplant (2014) 0.75
A Bayesian Model to Predict Right Ventricular Failure Following Left Ventricular Assist Device Therapy. JACC Heart Fail (2016) 0.75
Ventricular assist devices: initial orientation. J Thorac Dis (2013) 0.75
Physiologic effects of continuous-flow left ventricular assist devices. J Surg Res (2016) 0.75
Diagnosing and treating the failing right heart. Curr Opin Cardiol (2015) 0.75
Mechanical circulatory support in the new era: an overview. Crit Care (2016) 0.75
Implantable continuous-flow right ventricular assist device: lessons learned in the development of a cleveland clinic device. Ann Thorac Surg (2012) 0.75
Impact of tricuspid valve surgery at the time of left ventricular assist device insertion on postoperative outcomes. ASAIO J (2014) 0.75
Biventricular VAD versus LVAD for right heart failure. Ann Cardiothorac Surg (2014) 0.75
Echocardiographic assessment for ventricular assist device placement. J Thorac Dis (2015) 0.75
Total artificial heart implantation for biventricular failure due to eosinophilic myocarditis. J Artif Organs (2017) 0.75
Systematic Left Ventricular Assist Device Implant Eligibility with Non-Invasive Assessment: The SIENA Protocol. J Cardiovasc Ultrasound (2017) 0.75
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med (2011) 11.99
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA (2010) 6.29
Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation. Circulation (2007) 5.99
Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation (2007) 4.67
Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med (2010) 4.31
Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol (2010) 4.27
Ischemic heart disease events triggered by short-term exposure to fine particulate air pollution. Circulation (2006) 3.76
Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat Med (2008) 3.67
A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II). Circulation (2012) 3.30
Management strategies for patients with pulmonary hypertension in the intensive care unit. Crit Care Med (2007) 3.23
Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol (2005) 3.13
The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med (2009) 3.05
Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza. Sci Transl Med (2010) 3.02
Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery. J Am Coll Cardiol (2013) 2.92
Netrins promote developmental and therapeutic angiogenesis. Science (2006) 2.83
Robo4 is a vascular-specific receptor that inhibits endothelial migration. Dev Biol (2003) 2.58
A critical role for elastin signaling in vascular morphogenesis and disease. Development (2003) 2.47
Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development (2004) 2.35
The axonal attractant Netrin-1 is an angiogenic factor. Proc Natl Acad Sci U S A (2004) 2.34
Irrelevance of the chromosome 9p21.3 locus for acute cardiovascular events and restenosis. JACC Cardiovasc Interv (2009) 2.20
Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol (2013) 2.18
Red cell distribution width is predictive of mortality in trauma patients. J Trauma Acute Care Surg (2013) 2.17
Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program. Ann Intern Med (2004) 2.13
Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography. Am J Cardiol (2008) 2.10
Effects of elastin haploinsufficiency on the mechanical behavior of mouse arteries. Am J Physiol Heart Circ Physiol (2005) 2.06
Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency. J Clin Invest (2003) 2.05
Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail (2005) 1.99
Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt vascular stability. Nature (2012) 1.96
Consensus statement: Palliative and supportive care in advanced heart failure. J Card Fail (2004) 1.95
Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. Heart Rhythm (2009) 1.95
Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and heart transplantation. J Heart Lung Transplant (2009) 1.91
Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population. Clin Chim Acta (2011) 1.83
Genetic and functional dissection of HTRA1 and LOC387715 in age-related macular degeneration. PLoS Genet (2010) 1.83
Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention. Am Heart J (2003) 1.80
Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study. J Thromb Thrombolysis (2006) 1.78
Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005. Circ Heart Fail (2009) 1.77
Incremental survival benefit with adherence to standardized heart failure core measures: a performance evaluation study of 2958 patients. J Card Fail (2008) 1.74
Slit2-Robo4 signalling promotes vascular stability by blocking Arf6 activity. Nat Cell Biol (2009) 1.73
The cost of medical management in advanced heart failure during the final two years of life. J Card Fail (2008) 1.71
Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci U S A (2008) 1.70
roundabout4 is essential for angiogenesis in vivo. Proc Natl Acad Sci U S A (2005) 1.69
Exceptional mortality prediction by risk scores from common laboratory tests. Am J Med (2009) 1.67
Impact of transforming growth factor-beta1 on atrioventricular node conduction modification by injected autologous fibroblasts in the canine heart. Circulation (2006) 1.66
Small GTPase R-Ras regulates integrity and functionality of tumor blood vessels. Cancer Cell (2012) 1.56
C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol (2002) 1.56
Lack of association of Helicobacter pylori infection with coronary artery disease and frequency of acute myocardial infarction or death. Am J Cardiol (2002) 1.55
Warfarin knowledge in patients with atrial fibrillation: implications for safety, efficacy, and education strategies. Cardiology (2010) 1.53
The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease. Am Heart J (2003) 1.50
The netrin receptor UNC5B promotes angiogenesis in specific vascular beds. Development (2008) 1.50
Doppler indexes of left ventricular systolic and diastolic function in relation to the arterial stiffness in a general population. J Hypertens (2016) 1.44
Antibody testing for cardiac antibody-mediated rejection: which panel correlates best with cardiovascular death? J Heart Lung Transplant (2010) 1.44
Usefulness of a complete blood count-derived risk score to predict incident mortality in patients with suspected cardiovascular disease. Am J Cardiol (2006) 1.43
Nonsense mutations in hERG cause a decrease in mutant mRNA transcripts by nonsense-mediated mRNA decay in human long-QT syndrome. Circulation (2007) 1.43
Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients. Ann Thorac Surg (2006) 1.43
Effect of ABO-incompatible listing on infant heart transplant waitlist outcomes: analysis of the United Network for Organ Sharing (UNOS) database. J Heart Lung Transplant (2009) 1.42
Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: results of a 12-month, single-blind, randomized, parallel-group, multicenter study. J Heart Lung Transplant (2006) 1.42
Improved long-term survival associated with stent deployment during percutaneous coronary interventions: results from a registry of 3399 patients. Am Heart J (2005) 1.40
Trends in early and late mortality in patients undergoing coronary catheterization for myocardial infarction: implications on observation periods and risk factors to determine ICD candidacy. Heart Rhythm (2011) 1.40
Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant (2011) 1.40
Early postoperative use of unfractionated heparin or enoxaparin is associated with increased surgical re-exploration for bleeding. Ann Thorac Surg (2005) 1.39
Improving outcomes with long-term "destination" therapy using left ventricular assist devices. J Thorac Cardiovasc Surg (2008) 1.39
Altered vascular remodeling in fibulin-5-deficient mice reveals a role of fibulin-5 in smooth muscle cell proliferation and migration. Proc Natl Acad Sci U S A (2005) 1.37
Association of vitamin D levels with incident depression among a general cardiovascular population. Am Heart J (2010) 1.37
Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization. J Heart Lung Transplant (2009) 1.37
Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice. J Clin Invest (2011) 1.36
Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor. Dev Biol (2003) 1.36
Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart. J Am Coll Cardiol (2010) 1.34
New insights into elastin and vascular disease. Trends Cardiovasc Med (2003) 1.32
Genetic variation at the 9p21 locus predicts angiographic coronary artery disease prevalence but not extent and has clinical utility. Am Heart J (2008) 1.29
Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol (2011) 1.28
Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications. Vascul Pharmacol (2005) 1.27
Elastin haploinsufficiency induces alternative aging processes in the aorta. Rejuvenation Res (2008) 1.26